
Multiple myeloma (MM) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051124

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

Multiple myeloma (MM) restriction and item codes

Do not share this attachment externally. See Freedom of Information -
Information Publication Scheme.
[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png]PBS
multiple myeloma (MM) restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

Multiple myeloma - newly diagnosed dual therapy - lenalidomide - initial
authority application (PB200)

Multiple myeloma - newly diagnosed monotherapy – lenalidomide - initial
authority application (PB291)

Multiple myeloma – newly diagnosed triple therapy – lenalidomide -
initial authority application (PB293)

Multiple myeloma - progressive disease – lenalidomide - initial
authority application (PB158)

Multiple myeloma – pomalidomide - initial authority application (PB214)

Services Australia website

Multiple myeloma

External websites

PBS schedule for multiple myeloma

                                   

-   Services Australia ABN 90 794 605 008 
